CompletedNot Applicable

Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study)

Norway40 participantsStarted 2007-09

Plain-language summary

An investigation where patients with chronic heart failure and cheyne stokes respiration, treated with adapitve servo ventilator, will improve their cardiac function and quality of life.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ejection fraction \<40% * NYHA class III-IV * Optimized therapy with drugs * Cheyne stokes respiration pattern \> 25% while sleeping * Age \< 85 years * clinical stability the last month before inclusion. Exclusion Criteria: * CABG less then 6 months ago * PCI treatment less then 3 months ago * Unstable angina pectoris * Acute coronary syndrome less then 3 months ago * Stroke less then 6 weeks ago * Thoracal myopathy * Advanced COPD

What they're measuring

Ejection fraction (measured with echocardiography) and inflammatory markers

Timeframe: 3 months

Trial details

NCT IDNCT00563693

SponsorUniversity of Oslo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-01

View on ClinicalTrials.gov More Heart Failure trials